Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3

Muskan Agarwal, Alex Liu, Blake T. Langlais, Konstantinos Leventakos, Nathan Y. Yu, Daniel Almquist, Rami Manochakian, Vinicius Ernani

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3'. Together they form a unique fingerprint.

Medicine & Life Sciences